Cronos Group Stock Pops As 2017 Sales Increase 636%

Cronos Group Inc. (CRON) announced financial results for the fourth quarter and fiscal year ended December 31, 2017, with fourth-quarter sales of $1.6 million, an increase of 274%. Annual sales for fiscal 2017 were $4.1 million, a 636% increase over 2016’s $554,000.

The company also recorded a gross profit for 2017 of $7.2 million versus 2016’s gross profit of $1.9 million. The net income for 2017 was $2.4 million, which was a nice improvement over 2016’s net loss of $1.1 million. The diluted net income per share for 2017 was one cent per share versus 2016’s loss of two cents per share.

“We are building Cronos Group with a focus on the long-term and 2017 set the foundation for the explosive growth we have already started realizing in 2018,” said Mike Gorenstein,” CEO of Cronos Group.  “We are extremely proud of all that our team has accomplished and look forward to a year of rapid increases in sales, commencing distribution in new markets, further developing disruptive intellectual property and launching new iconic brands.”

Beacon Securities analyst Vahan Ajamian said, “Revenue for the quarter was $1.6MM – right in the middle of the implied range previously provided of $1.3-$1.9MM, but below our forecast of $1.8MM and the other analyst’s forecast of $2.0MM.”

Sales increased by $3.5 million, or 636%, to $4.1 million in FY 2017. The average selling price of whole flower is $8.50 per gram and processing costs are estimated to be $0.82 per gram with selling costs estimated to be $0.97 per gram. Cronos strengthened liquidity by $89.6mm, including a $40.0mm senior secured credit facility and $49.6mm in gross proceeds from three common share offerings.

So far in 2018, the company listed on the NASDAQ exchange and announced a joint venture with MedMen in the U.S.

Cronos also put a lot of effort into the rebranding of Peace Naturals with new packaging, a new logo, a revised website, a new shopping portal experience, and new products such as strain-specific oils and limited edition cultivars.

In addition, Cronos launched Peace Naturals strain-specific cannabis oils without using ethanol. In a company statement, Cronos said, “This is important because of the “entourage effect,” or the concept that all cannabis compounds work together synergistically to yield the desired therapeutic effect.”  On January 22, 2018, Peace Naturals received a dealer’s license pursuant to the Narcotic Control Regulations and CDSA from Health Canada for the possession, sale, transportation, and delivery of controlled substances including cannabis, tetrahydrocannabinol and cannabidiol.  The license allows Peace Naturals to export medical cannabis extracts, including concentrated oil and resin products, internationally.

International

The company said that 15% of its sales came from Germany. On the earnings call, the company said that everything was on track for Israel and while there has been market noise about disruptions, they have not experienced any. Cronos launched a strategic joint venture in Israel, with Israeli agricultural collective settlement Kibbutz Gan Shmuel to produce and distribute medical cannabis.The company announced a strategic joint for a venture in Australia for the research, production, manufacture, and distribution of medical cannabis and it owns a 50% equity interest in Cronos Australia.

Stock Performance

There are currently three analysts covering the company according to Yahoo Finance with an average price target of C$7.85 for the stock trading on the Toronto Exchange. That stock is currently trading at C$8.88. The stock on the NASDAQ exchange was lately trading at $7.14, down from its 52-week high of $10.39, but higher than its year low of $5.12.

 

Debra Borchardt

Debra BorchardtDebra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.


One comment

  • Avatar
    Bob

    April 30, 2018 at 12:02 pm

    This company are the criminals in Cannabis in Canada. Tax havens fund Canadian pot companies They are Tax evaders and money launders.

    They took advantage of offshore funds

    ABCANN GLOBAL

    Cayman Islands: $ 12.4 million
    Guernsey: $ 150,000

    AURORA CANNABIS

    Cayman Islands: $ 32.5 million
    Barbados: $ 202,500

    CANNTRUST HOLDINGS

    Cayman Islands: $ 2 million
    Bahamas: $ 549,000
    Switzerland: $ 110,000
    Belize: $ 50,000
    Channel Islands: $ 75,000

    SUPREME CANNABIS CORPORATION

    Switzerland: $ 100,000
    Belize: $ 100,000
    Bahamas: $ 130,000
    Cayman Islands: $ 10.5 million
    Guernsey: $ 366,000
    United Arab Emirates: $ 25,000

    CANNABIS WHEATON INCOME CORP

    Singapore: $ 10,000
    Cayman Islands: $ 20.5 million
    Switzerland: $ 20,000

    HYDROPOTHECARY

    Cayman Islands: $ 15 million
    United Arab Emirates: $ 700,000
    Bahamas: $ 751,500

    DELSHEN THERAPEUTICS (48 North)

    British Virgin Islands: $ 3 million
    Switzerland: $ 200,000

    CRONOS GROUP

    Singapore: $ 225,000

    NEWSTRIKE RESOURCES

    Bahamas: $ 47,500
    Singapore: $ 70,000
    Switzerland: $ 24,400

    EMBLEM CANNABIS CORP

    Panama: $ 200,000
    Switzerland: $ 188,650
    Bahamas: $ 308,550
    Cayman Islands: $ 8.3 million
    Dominica: $ 47,190
    Belize: $ 40,250
    British Virgin Islands: $ 21,275
    Isle of Man: $ 57,500
    Luxembourg: $ 69,000

    GOLDEN LEAF HOLDING

    Bahamas: $ 308,000
    Cayman Islands: $ 5.7 million

    INVICTUS ®

    Seychelles: $ 765,000
    Cayman Islands: $ 14.13 million
    Switzerland: $ 27,000
    Luxembourg: $ 78,750
    United Arab Emirates: $ 10,500

    MARICANN GROUP

    Cayman Islands: $ 9.76 million
    Bahamas: $ 50,000

    THE GREEN ORGANIC DUTCHMAN

    Singapore: $ 9900
    Hong Kong: $ 47,850
    Barbados: $ 99,825
    Bermuda: $ 115,500
    Cayman Islands: $ 553,000
    Monaco: $ 34,980
    United Arab Emirates: $ 24,750
    Dominica: $ 123,750
    Luxembourg: $ 23,098
    Switzerland: $ 50,000
    Curacao: $ 11,500
    Aruba: $ 5750
    Panama: $ 80,500
    Malta: $ 10,000
    British Virgin Islands: $ 10,000
    Belize: $ 75,000
    Marshall Islands: $ 10,000

    HARVEST ONE CANNABIS

    Cayman Islands: $ 4.37M
    Luxembourg: $ 600,000
    Belize: $ 99,750
    Bahamas: $ 225,000
    Hong Kong: $ 499,999

    WEEDMD

    Cayman Islands: $ 2.28 million
    Bahamas: $ 25,000

    DELTA 9 BIOTECH

    Belize: $ 22,000
    Cayman Islands: $ 25,000
    Singapore: $ 300,000

    DOJA CANNABIS

    Cayman Islands: $ 12.5 million
    Bahamas: $ 70,000

    INDIVA LIMITED

    Cayman Islands: $ 199,500

    FV PHARMA

    Panama: $ 50,000
    Malta: $ 50,000
    Hong Kong: $ 2 million
    Belize: $ 50,000
    Bahamas: $ 10,000

    SUNDIAL GROWERS

    Bermuda: $ 540,000

    TOTAL OFFSHORE FUNDS: $ 165.2 MILLION

    https://translate.google.com/translate?act=url&depth=1&hl=en&ie=UTF8&nv=1&prev=_t&rurl=translate.google.ca&sl=auto&sp=nmt4&tl=en&u=http://www.journaldequebec.com/2018/01/22/les-paradis-fiscaux-financent-les-firmes-de-pot-canadiennes

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 20 hours

Clever Leaves To List On NASDAQ $SAMA $NDAQ ⁦@clever_leaves⁩

@GreenMarketRpt – 23 hours

Leafs By Snoop Is Most Recognizable Brand Says New Study $CGC ⁦@SnoopDogg⁩ ⁦@MERRYJANE⁩ #LBS…

Back to Top

You have Successfully Subscribed!